Taylor Sandison
2023
In 2023, Taylor Sandison earned a total compensation of $884.1K as Chief Medical Officer at Cidara Therapeutics, a 22% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $167,600 |
|---|---|
| Option Awards | $128,592 |
| Salary | $487,100 |
| Stock Awards | $90,900 |
| Other | $9,900 |
| Total | $884,092 |
Sandison received $487.1K in salary, accounting for 55% of the total pay in 2023.
Sandison also received $167.6K in non-equity incentive plan, $128.6K in option awards, $90.9K in stock awards and $9.9K in other compensation.
Rankings
In 2023, Taylor Sandison's compensation ranked 1,345th out of 2,978 executives tracked by ExecPay. In other words, Sandison earned more than 54.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,345 out of 2,978 | 55th |
Division Manufacturing | 805 out of 1,637 | 51st |
Major group Chemicals And Allied Products | 531 out of 906 | 41st |
Industry group Drugs | 518 out of 869 | 40th |
Industry Biological Products, Except Diagnostic Substances | 148 out of 211 | 30th |
Source: SEC filing on June 3, 2024.
Sandison's colleagues
We found two more compensation records of executives who worked with Taylor Sandison at Cidara Therapeutics in 2023.
News
Cidara Therapeutics CEO Jeffrey Stein's 2023 pay jumps 24% to $1.6M
June 3, 2024
Cidara Therapeutics CEO Jeffrey Stein's 2022 pay falls 23% to $1.3M
April 27, 2023
Cidara Therapeutics CEO Jeffrey Stein's 2021 pay jumps 26% to $1.6M
April 29, 2022
Cidara Therapeutics CEO Jeffrey Stein's 2019 pay rises 6% to $1.5M
April 29, 2020
Cidara Therapeutics CEO Jeffrey Stein's 2018 pay falls 25% to $1.4M
April 26, 2019